PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsSdd
Sdd
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
34 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PneumoniaD011014EFO_0003106——1—1—2
Klebsiella infectionsD007710EFO_1001353————1—1
Colorectal neoplasmsD015179—————1—1
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Ventilator-associated pneumoniaD053717EFO_1001865J95.851—12——2
BacteremiaD016470EFO_0003033R78.81—12——2
Critical illnessD016638————1——1
SepsisD018805HP_0100806A41.9——1——1
Septic shockD012772—A48.3——1——1
Esophageal neoplasmsD004938—C15——1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Multiple myelomaD009101—C90.012———2
Plasma cell neoplasmsD054219——12———2
Hepatitis cD006526—B19.2—1———1
Chronic hepatitis cD019698EFO_0004220B18.2—1———1
HepatitisD006505HP_0012115K75.9—1———1
Hepatitis aD006506EFO_0007305B15—1———1
Hematologic neoplasmsD019337———1———1
Non-hodgkin lymphomaD008228—C85.9—1———1
LymphomaD008223—C85.9—1———1
B-cell chronic lymphocytic leukemiaD015451—C91.1—1———1
Show 4 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients———10————10
InfectionsD007239EFO_0000544—1————1
Hiv infectionsD015658EFO_0000764B201————1
Acquired immunodeficiency syndromeD000163EFO_0000765B201————1
AspergillosisD001228EFO_0007157B441————1
Invasive pulmonary aspergillosisD055744—B44.01————1
NeuralgiaD009437EFO_0009430—1————1
Biological availabilityD001682——1————1
HypercholesterolemiaD006937HP_0003124—1————1
Type 2 diabetes mellitusD003924EFO_0001360E111————1
Show 2 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Coronary artery diseaseD003324—I25.1————22
Heart failureD006333HP_0001635I50————22
Coronary diseaseD003327——————11
Myocardial ischemiaD017202EFO_1001375I20-I25————11
HysterectomyD007044EFO_0003881—————11
Atrial fibrillationD001281EFO_0000275I48.0————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification
Unknown
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use